Insider Buy: Molecular Templates
5:27PM ET 6/21/2022 MT NewswiresKevin M. Lalande, 10% Owner, Director, on June 13, 2022, executed a purchase for 222,000 shares in Molecular Templates (MTEM) for $198,380. Following the...
--BofA Securities Downgrades Molecular Templates to Underperform From Buy, Sets Price Target at $1.50
10:43AM ET 5/27/2022 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Stifel Adjusts Molecular Templates' Price Target to $9 From $11, Reiterates Buy Rating
8:50AM ET 5/16/2022 MT NewswiresMolecular Templates (MTEM) has an average rating of buy and price targets ranging from $4.50 to $18, according to analysts polled by Capital IQ. (MT...
-- Earnings Flash (MTEM) MOLECULAR TEMPLATES Reports Q1 Revenue $8.5M
4:31PM ET 5/12/2022 MT Newswires...
Barclays Adjusts Molecular Templates' Price Target to $4.50 from $8, Keeps Overweight Rating
10:57AM ET 3/30/2022 MT NewswiresMolecular Templates (MTEM) has an average rating of buy and price targets ranging from $4.50 to $18, according to analysts polled by Capital IQ. (MT...
After Hours Watch List Scorecard: ABOS, MTEM, NEO,
5:31PM ET 3/29/2022 MT NewswiresHere's how the stocks on Monday's After Hours Watch List performed during today's regular session: AFTER HOURS REGULAR SESSION ABOS +16.7% ...
Molecular Templates Narrows Q4 Loss Amid Revenue Surge; Stock Rises After-Hours
5:03PM ET 3/28/2022 MT NewswiresMolecular Templates (MTEM) late Monday reported a Q4 net loss of $0.18 per share, paring a $0.57 loss for the biopharmaceuticals company during the same...
-- Earnings Flash (MTEM) MOLECULAR TEMPLATES Reports Q4 Revenue $18M
4:30PM ET 3/28/2022 MT Newswires...
--Oppenheimer Lowers Price Target for Molecular Templates to $9 From $13, Maintains Outperform Rating
9:05AM ET 12/01/2021 MT Newswires(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Molecular Templates Obtains FDA Fast Track Designation for Lung Cancer Treatment
10:01AM ET 11/18/2021 MT NewswiresMolecular Templates (MTEM) on Thursday said that the US Food and Drug Administration has granted fast track designation for MT-6402 for the treatment of...